A clinical trial to study the effects Flecainide on HV interval in patients with symptomatic Bifascicular block
Not Applicable
- Conditions
- Health Condition 1: I452- Bifascicular block
- Registration Number
- CTRI/2020/12/029543
- Lead Sponsor
- King George Medical University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
study population will consist of symptomatic patient admitted with bifasicular block for permanent pacing
Exclusion Criteria
patient with established indication for pacing.
1- Third degree AV block( CHB)
2- Mobitz II
3-Advanced AVB
4-LVEF <35%
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method to access the effect of flecainide on infrahasian AV conductionTimepoint: during the study- <br/ ><br> Via measurement of HV interval 100 or more than 100 after flecainide .
- Secondary Outcome Measures
Name Time Method to know the effect of incremental pacing on HV interval in patients with BFB after flecainideTimepoint: at the end of study